These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35208489)

  • 1. Doppler Echocardiography-Guided Heart Rate Modulation Therapy Using Ivabradine in a Patient with Systolic Heart Failure.
    Imamura T; Kinugawa K
    Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Doppler echocardiography-guided ivabradine therapy.
    Izumida T; Imamura T; Kinugawa K
    Heart Vessels; 2023 Jan; 38(1):49-55. PubMed ID: 35789418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal Heart Rate Modulation Using Ivabradine.
    Imamura T; Kinugawa K
    Int Heart J; 2021 Jul; 62(4):717-721. PubMed ID: 34276025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Implications of Ivabradine in the Contemporary Era.
    Imamura T
    Medicina (Kaunas); 2024 Feb; 60(2):. PubMed ID: 38399590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of Doppler Echocardiography-guided Heart Rate Modulation Using Ivabradine.
    Hori M; Imamura T; Narang N; Kinugawa K
    Intern Med; 2021 Dec; 60(24):3873-3877. PubMed ID: 34148961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication of Ivabradine Therapy in Up-Titrating Beta-Blocker Dose in Patients with Systolic Dysfunction.
    Imamura T; Onoda H; Uchida K; Kinugawa K
    Int Heart J; 2021 Nov; 62(6):1305-1309. PubMed ID: 34744149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-life indications to ivabradine treatment for heart rate optimization in patients with chronic systolic heart failure.
    Tondi L; Fragasso G; Spoladore R; Pinto G; Gemma M; Slavich M; Godino C; Salerno A; Montanaro C; Margonato A
    J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):351-356. PubMed ID: 29762337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of optimal heart rate on left ventricular reverse remodeling and functional improvement in patients with systolic heart failure.
    Izumida T; Imamura T; Ueno Y; Tanaka S; Kataoka N; Nakamura M; Kinugawa K
    Heart Vessels; 2021 Nov; 36(11):1688-1693. PubMed ID: 33956182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial.
    Komajda M; Isnard R; Cohen-Solal A; Metra M; Pieske B; Ponikowski P; Voors AA; Dominjon F; Henon-Goburdhun C; Pannaux M; Böhm M;
    Eur J Heart Fail; 2017 Nov; 19(11):1495-1503. PubMed ID: 28462519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Implications of Mitral Valve Inflow Pattern Overlap during Ivabradine Therapy.
    Imamura T; Hori M; Narang N; Besser S; Kinugawa K
    Int Heart J; 2022; 63(1):43-48. PubMed ID: 35095075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of heart rate optimization in patients with heart failure.
    Hori M; Imamura T; Kinugawa K
    J Cardiol Cases; 2021 Apr; 23(4):163-165. PubMed ID: 33841593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to consider target heart rate in patients with systolic heart failure.
    Izumida T; Imamura T; Nakamura M; Fukuda N; Kinugawa K
    ESC Heart Fail; 2020 Oct; 7(5):3231-3234. PubMed ID: 32592292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ivabradine Improves Cardiac Function and Increases Exercise Capacity in Patients with Chronic Heart Failure.
    Pei H; Miao W; Xie WZ; Wang W; Zhao D; Su GH; Zhao Z
    Int Heart J; 2019 Jul; 60(4):899-909. PubMed ID: 31308326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ivabradine in Heart Failure: The Representativeness of SHIFT (Systolic Heart Failure Treatment With the IF Inhibitor Ivabradine Trial) in a Broad Population of Patients With Chronic Heart Failure.
    Das D; Savarese G; Dahlström U; Fu M; Howlett J; Ezekowitz JA; Lund LH
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28903983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early NT-proBNP decrease with ivabradine in ambulatory patients with systolic heart failure.
    Sargento L; Satendra M; Longo S; Lousada N; Palma dos Reis R
    Clin Cardiol; 2013 Nov; 36(11):677-82. PubMed ID: 23929789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of chronic heart failure affects outcomes with preserved effects of heart rate reduction with ivabradine: findings from SHIFT.
    Böhm M; Komajda M; Borer JS; Ford I; Maack C; Tavazzi L; Moyne A; Swedberg K;
    Eur J Heart Fail; 2018 Feb; 20(2):373-381. PubMed ID: 29027329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiation of ivabradine in cardiogenic shock.
    Chiu MH; Howlett JG; Sharma NC
    ESC Heart Fail; 2019 Oct; 6(5):1088-1091. PubMed ID: 31332966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained-Release Ivabradine Hemisulfate in Patients With Systolic Heart Failure.
    Ye F; Wang X; Wu S; Ma S; Zhang Y; Liu G; Liu K; Yang Z; Pang X; Xue L; Lu S; Zhong M; Li J; Yu H; Lou D; Cui D; Xie X; Wang J;
    J Am Coll Cardiol; 2022 Aug; 80(6):584-594. PubMed ID: 35926931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.
    Bouabdallaoui N; O'Meara E; Bernier V; Komajda M; Swedberg K; Tavazzi L; Borer JS; Bohm M; Ford I; Tardif JC
    ESC Heart Fail; 2019 Dec; 6(6):1199-1207. PubMed ID: 31591826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ivabradine in heart failure: a meta-analysis of heart failure patients with reduced versus preserved ejection fraction.
    Tóth N; Soós A; Váradi A; Hegyi P; Tinusz B; Vágvölgyi A; Orosz A; Solymár M; Polyák A; Varró A; Farkas AS; Nagy N
    Can J Physiol Pharmacol; 2021 Nov; 99(11):1159-1174. PubMed ID: 34636643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.